0001127602-23-002457.txt : 20230127 0001127602-23-002457.hdr.sgml : 20230127 20230127163846 ACCESSION NUMBER: 0001127602-23-002457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230126 FILED AS OF DATE: 20230127 DATE AS OF CHANGE: 20230127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCubbin Quentin CENTRAL INDEX KEY: 0001842009 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 23563739 MAIL ADDRESS: STREET 1: C/O FREQUENCY THERAPEUTICS, INC. STREET 2: 10 PRESIDENTIAL WAY, 2ND FLOOR CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2023-01-26 0001703647 Frequency Therapeutics, Inc. FREQ 0001842009 McCubbin Quentin 75 HAYDEN AVE SUITE 300 LEXINGTON MA 02421 1 Chief Manufacturing Officer Restricted Stock Unit 2023-01-26 4 A 0 105000 0 A Common Stock 105000 105000 D Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will vest in four equal annual installments beginning on January 26, 2024. /s/ James P. Abely, Attorney-in-Fact for Quentin McCubbin 2023-01-27